Cellebrite DI (CLBT) Competitors

Cellebrite DI (NASDAQ:CLBT) and N-able (NYSE:NABL) are both mid-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

Which has more volatility and risk, CLBT or NABL?

Cellebrite DI has a beta of 1.51, indicating that its stock price is 51% more volatile than the S&P 500. Comparatively, N-able has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500.

Which has better earnings and valuation, CLBT or NABL?

N-able has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than N-able, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cellebrite DI	$325.11M	7.16	-$81.10M	-$0.43	-26.30
N-able	$421.88M	5.54	$23.41M	$0.14	90.36

Does the media refer more to CLBT or NABL?

In the previous week, N-able had 8 more articles in the media than Cellebrite DI. MarketBeat recorded 12 mentions for N-able and 4 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.38 beat N-able's score of 0.51 indicating that Cellebrite DI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cellebrite DI	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
N-able	0 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders hold more shares of CLBT or NABL?

45.9% of Cellebrite DI shares are owned by institutional investors. Comparatively, 96.4% of N-able shares are owned by institutional investors. 5.7% of Cellebrite DI shares are owned by insiders. Comparatively, 1.4% of N-able shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Does the MarketBeat Community favor CLBT or NABL?

Cellebrite DI received 7 more outperform votes than N-able when rated by MarketBeat users. However, 62.07% of users gave N-able an outperform vote while only 53.19% of users gave Cellebrite DI an outperform vote.

Company	Underperform	Outperform
Cellebrite DI	Outperform Votes 25 53.19%	Underperform Votes 22 46.81%
N-able	Outperform Votes 18 62.07%	Underperform Votes 11 37.93%

Is CLBT or NABL more profitable?

N-able has a net margin of 6.27% compared to Cellebrite DI's net margin of -24.94%. Cellebrite DI's return on equity of 173.14% beat N-able's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cellebrite DI	-24.94%	173.14%	12.09%
N-able	6.27%	4.38%	2.66%

Do analysts prefer CLBT or NABL?

Cellebrite DI currently has a consensus target price of $12.42, indicating a potential upside of 9.40%. N-able has a consensus target price of $15.50, indicating a potential upside of 22.63%. Given N-able's higher probable upside, analysts plainly believe N-able is more favorable than Cellebrite DI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cellebrite DI	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
N-able	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Cellebrite DI and N-able tied by winning 9 of the 18 factors compared between the two stocks.